中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Surveillance of hiv-1 drug resistance in xinjiang: high prevalence of k103n in treatment-naive individuals

文献类型:期刊论文

作者Shu, Zhanjun1,4; Chen, Yuying2,3; Abudureyimu, Aihemaiti1; Li, Tingting2,3; Yuan, Ting2; Ma, Jianping1; Li, Xiaochun4; Ma, Xiulan1; Jang, Chengyuan4; Bao, Gang4
刊名Archives of virology
出版日期2018-08-01
卷号163期号:8页码:2111-2119
ISSN号0304-8608
DOI10.1007/s00705-018-3825-7
通讯作者Sun, binlian(binlian17@jhun.edu.cn) ; Yang, rongge(ryang@wh.iov.cn)
英文摘要To identify transmitted and acquired hiv-1 drug resistance mutations in xinjiang, china, we collected the peripheral blood of 50 treated and 50 treatment-naive hiv-1-infected individuals in this region. we successfully amplified 36 reverse transcriptase and 42 protease gene sequences of hiv-1 from 51 individuals and identified mutations associated with resistance to reverse transcriptase (rt) and protease (pr) inhibitors (rtis and pis) according to stanford drug resistance database. among the drug-treated individuals, the results showed that k103n in the rt region was the most frequent mutation, found in 67% (6/9) of the cases, followed by m184v with 56% (5/9). five individuals had both nucleoside and non-nucleoside reverse transcriptase inhibitor resistance mutations after more than 12 months of treatment. among the untreated individuals, 33% (9/27) were found to harbor drug resistance mutations in the rt gene. k103n occurred at the highest rate, accounting for 22% (6/27), followed by p225h (7%) and y188l (4%). neither of the two groups showed any major resistance mutations to pis. our study revealed that the prevalence of drug resistance was relatively high in xinjiang and that k103n occurred at the highest rate. these results suggest that it is important to carry out hiv drug resistance testing, especially for the k103n mutation in the rt region, before and during the treatment process. this study may help to guide art strategies in the xinjiang region.
WOS关键词SUB-SAHARAN AFRICA ; ANTIRETROVIRAL THERAPY ; CHINA ; MUTATIONS ; RATES
WOS研究方向Virology
WOS类目Virology
语种英语
WOS记录号WOS:000440727000014
出版者SPRINGER WIEN
URI标识http://www.irgrid.ac.cn/handle/1471x/2373251
专题武汉病毒研究所
通讯作者Sun, Binlian; Yang, Rongge
作者单位1.Xinjiang Med Univ, Affiliated Hosp 4, Urumqi, Peoples R China
2.Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Res Grp HIV Mol Epidemiol & Virol 1, Wuhan 430071, Hubei, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Sixth Peoples Hosp Xinjiang Uygur Autonomous Reg, Urumqi, Peoples R China
5.Jianghan Univ, Sch Med, Wuhan 430056, Hubei, Peoples R China
推荐引用方式
GB/T 7714
Shu, Zhanjun,Chen, Yuying,Abudureyimu, Aihemaiti,et al. Surveillance of hiv-1 drug resistance in xinjiang: high prevalence of k103n in treatment-naive individuals[J]. Archives of virology,2018,163(8):2111-2119.
APA Shu, Zhanjun.,Chen, Yuying.,Abudureyimu, Aihemaiti.,Li, Tingting.,Yuan, Ting.,...&Yang, Rongge.(2018).Surveillance of hiv-1 drug resistance in xinjiang: high prevalence of k103n in treatment-naive individuals.Archives of virology,163(8),2111-2119.
MLA Shu, Zhanjun,et al."Surveillance of hiv-1 drug resistance in xinjiang: high prevalence of k103n in treatment-naive individuals".Archives of virology 163.8(2018):2111-2119.

入库方式: iSwitch采集

来源:武汉病毒研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。